Answers are grounded in this paper and cite their sources.
This cohort study found that, among patients with advanced NSCLC, the uptake of ICIs after US Food and Drug Administration approval was rapid across all age groups. However, corresponding survival gains were modest, particularly in the oldest patients.
No takes yet. Share an insight, caveat, or question.
Voruganti et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: